• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. There aren't many studies on how long-term exposure may affect the pregnant fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Pregnant women who use ADHD medications need to balance the advantages of taking them against the potential risks to the foetus. Physicians do not have the data needed to give clear guidelines however they can provide information on the risks and benefits to assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy were not at a higher risk of fetal malformations or structural birth defects. Researchers used a large population-based study of case control to examine the prevalence of major structural defects in infants who were born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to ensure that the classification was accurate and to reduce any bias.

The research conducted by the researchers was not without limitations. Most important, they were unable to distinguish the effects of the medication from the disorder at hand. This limitation makes it difficult for researchers to determine whether the few associations observed between the groups that were exposed to the use of medication, or if they were confounded by the presence of comorbidities. The researchers did not look at long-term outcomes for the offspring.

The study did find that infants whose mothers had taken ADHD medications during pregnancy were at a slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or cut back on their medications prior to or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not affected by the stimulant medication that was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher chance of having to have a caesarean section or a baby that scored low on the Apgar scale (less than 7). These increases did not appear to be affected by the type of medication that was used during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medications during early pregnancies may be offset by the greater benefits to both mother and baby of continuing treatment for the woman's condition. Physicians should discuss this with their patients and, when possible, assist them in developing strategies to improve coping skills that can lessen the negative impact of her condition on her daily functioning and relationships.

Medication Interactions

Many doctors are faced with the decision of whether to continue treatment or stop it during pregnancy as more women are diagnosed with adhd medication weight loss uk. Most of the time, these decisions are made in the absence of solid and reliable evidence either way, so physicians have to weigh their experience from their own experiences, those of other doctors, and what research suggests on the subject and their best adhd Medication for someone with anxiety (https://bjerre-chu-2.technetbloggers.de/) judgment for each individual patient.

In particular, the issue of possible risks to the infant can be difficult. The research on this subject is based on observations rather than controlled studies, and many of the findings are contradictory. The majority of studies restrict their analysis to live births, which can underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study presented in the journal club addresses these issues by analyzing data on live and deceased births.

The conclusion: While some studies have shown that there is a positive correlation between ADHD medications and the risk of certain birth defects, other studies have not found any evidence of a link, and most studies have a neutral or slight negative effect. As a result, a careful risk/benefit analysis must be done in each instance.

For a lot of women with ADHD and ADD, the decision to stop medication can be difficult, if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adult adhd medication uk medications during pregnancy can cause depression and feelings of loneliness. A decrease in medication could affect the ability to safely drive and perform work-related tasks, which are crucial aspects of normal life for people with ADHD.

She suggests women who are unsure about whether to keep or stop medication in light of their pregnancy, consider informing family members, friends and colleagues about the condition, its effects on daily functioning, and best adhd medication for someone with anxiety on the advantages of staying on the current treatment plan. It can also help women feel more confident in her decision. Certain medications can be passed through the placenta. If the patient decides to not take her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug may be transferred to her baby.

Risk of Birth Defects

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns over the impact that these drugs could have on foetuses. A study that was published in the journal Molecular Psychiatry adds to the body of information on this topic. With two massive data sets researchers were able examine more than 4.3 million pregnancies to determine whether the use of stimulant medications increased the risk of birth defects. Researchers discovered that, while the overall risk is low, the first trimester ADHD medication use was associated with slightly higher rates of specific heart defects like ventriculoseptal defects.

The researchers of the study found no connection between early medication use and other congenital anomalies, such as facial clefting or club foot. The results are in the same vein as previous studies that have shown a small, but significant increase in cardiac malformations for women who began taking ADHD medication before the time of pregnancy. The risk was higher in the latter half of pregnancy, when many women decide to stop taking their medication.

Women who took ADHD medication during the first trimester were more likely need a caesarean, have a low Apgar after delivery, and have a baby who needed breathing assistance at birth. However, the authors of the study were unable to eliminate selection bias by limiting the study to women who did not have other medical issues that could be a contributing factor to these findings.

Researchers hope that their research will inform physicians when they see pregnant women. They advise that while discussing the risks and benefits is crucial however, the decision to stop or keep treatment should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors warn that, although stopping the medication for adhd and anxiety in adults is an option to look into, it is not advised because of the high incidence of depression and mental health issues among women who are pregnant or who have recently given birth. Further, research shows that women who stop taking their medication will have a harder time adjusting to a life without them after the baby is born.

Nursing

The responsibilities of being a new mom can be overwhelming. Women who suffer from ADHD may face a lot of challenges when they must manage their symptoms, go to doctor appointments, prepare for the birth of a baby and adjust to new adhd medication uk routines. Therefore, many women choose to continue taking their ADHD medication throughout the pregnancy.

The majority of stimulant drugs are absorbed by breast milk in very small amounts, so the risk to breastfeeding infant is minimal. The amount of exposure to medications will vary based on the dosage the medication is administered, its frequency and the time of the day. Additionally, different medications enter the infant's system differently through the gastrointestinal tract as well as breast milk. The impact of this on a newborn infant is not fully understood.

Because of the lack of research, some doctors may be inclined to discontinue stimulant medications during the pregnancy of a woman. This is a complicated decision for the patient, who must weigh the benefits of continuing her medication against the possible dangers to the embryo. As long as there is no more information, GPs should ask all pregnant patients about their history of ADHD and whether they are taking or planning to take medication during the perinatal time.

Many studies have shown that women can continue taking their ADHD medication in a safe manner during pregnancy and while breast-feeding. In response, a growing number of patients are opting to continue their medication. They have concluded after consulting with their doctors that the benefits of continuing their current medication far outweigh any potential risks.

Women who suffer from ADHD who are planning to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the pros and cons of continuing treatment. This includes non stimulant adhd medication list-pharmacological methods. Psychoeducation is also necessary to help pregnant women suffering from ADHD recognize the signs and underlying disorder. They should also learn about treatment options and strengthen strategies for coping. This should involve an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Counselling for pregnancy should include the discussion of a plan for management for both mother and child, monitoring for signs of deterioration and, if necessary, adjustments to the medication regimen.